BioLineRx Statistics
NASDAQ: BLRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.21-0.0872 (-3.80%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
BioLineRx by the numbers
BioLineRx has a market capitalization of $11.0 million based on 4.98M shares outstanding. With trailing EPS of $0.00, BioLineRx is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 16.3% below its 50-day average and 21.6% below its 200-day average.
Average daily trading volume is 16.15K shares, or about $35,604 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BLRX valuation vs. peer median
| Metric | BLRX | Peer median | Difference |
|---|---|---|---|
| Market cap | $10.98M | $11.08M | -1% |
| Avg. volume | 16.15K | 567.08K | -97% |
Peer median across 8 companies: VTGN, GTBP, KPRX, TOVX, APUS, ADIL, MDCX, PHIO.
Valuation
- Market cap
- $10.98M
- EPS (TTM)
- $0.00
- Shares outstanding
- 4.98M
Price and trading
- Previous close
- 2.29
- Open
- 2.28
- Day range
- 2.16 – 2.37
- 52-week range
- 2.15 – 4.50
- 52-week change
- -50.34%
- Beta
- —
- Volume
- 24.13K
- Average volume
- 16.15K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 31, 2026
Additional statistics
- Market Cap
- 10.98M
- Forward Pe
- -0.88
- Eps
- 0.00
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 4.50
- Week52 Low
- 2.15
- Avg Volume
- 16,147.00
- Shares Outstanding
- 4.98M
- Ma50
- 2.63
- Ma200
- 2.81
- Earnings Date
- Aug 31, 2026
- Pct From52w High
- -51.00%
- Pct From52w Low
- 2.56%